Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes

Core Viewpoint - Exousia Pro, Inc. is set to conduct an Institutional Review Board (IRB) study aimed at transforming the cannabinoid edible and nutraceutical markets through enhanced efficacy of CBD-loaded exosomes in oral delivery [1] Company Summary - Exousia Pro, Inc. is a clinical-stage biotechnology company focused on advanced exosome-based therapies [1] Industry Summary - The upcoming IRB study is expected to demonstrate significantly improved effectiveness of CBD-loaded exosomes, which could have a major impact on the cannabinoid edible and nutraceutical sectors [1]